Author:
Massari Francesco,Bria Emilio,Maines Francesca,Milella Michele,Giannarelli Diana,Cognetti Francesco,Pappagallo Giovanni,Tortora Giampaolo,Porta Camillo
Reference30 articles.
1. The epidemiology of renal cell carcinoma;Ljungberg;Eur Urol,2011
2. Surveillance following radical or partial nephrectomy for renal cell carcinoma;Lam;Curr Urol Rep,2005
3. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system;Lam;J Urol,2005
4. Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects;Adler;J Biol Response Mod,1987
5. Aitchison M, Bray CA, Van Poppel H, et al. Final results from an EORTC (GU Group)/NCRI randomized phase III trial of adjuvant interleukin-2, interferon alpha, and 5-fluorouracil in patients with a high risk of relapse after nephrectomy for renal cell carcinoma (RCC). J Clin Oncol 29(suppl):abstract 4505. Available at: http://www.asco.org. Accessed: June 2, 2013.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献